Ever felt that pang of frustration when your code, which looked perfectly logical on paper, just refuses to behave? You’re not alone. Every developer, from the seasoned pro to the absolute beginner, ...
Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that ...
A shareholder class action lawsuit has been filed against Replimune Group, Inc. (“Replimune”) (NASDAQ: REPL). The lawsuit ...
Zed is a speed demon you can't ignore.
Since the large language model (LLM) explosion started, companies have been trying to solve the problem of overflowing inboxes by using AI to categorize emails and draft replies that sound like you.
Your IT band feels super tight and achy, and the discomfort intensifies as you run. So you take what seems like the logical next step to reduce your pain: You foam roll the heck out of it. “Everybody ...
Replimune Group, Inc.'s RP1 has failed at the FDA twice, but Makary's resignation keeps a resubmission possible. REPL's cash runway stands at under a year; workforce cuts and RP1 discontinuation are ...
Journal Editorial Report: Eric Swalwell's exit jolts the California governor’s race. Photo: Tom Williams/Zuma Press/Chip Somodevilla/Getty Images Robert F. Kennedy Jr. doesn’t like our criticism of ...
A Woburn biotechnology company is set to lay off dozens of Massachusetts employees after federal regulators rejected its lead cancer treatment for the second time. According to a Worker Adjustment and ...
News is breaking today that Replimune Group, Inc.'s (REPL) Biologics License Application ("BLA") requesting approval for its drug candidate RP1 (vusolimogene oderparepvec) in the indication of anti-PD ...